Elekta AB Class B EKTA B

Morningstar Rating
SEK 70.75 +0.70 (1.00%)
View Full Chart

Company Report

Price vs Fair Value

EKTA B is trading at a 417% premium.
Price
SEK 70.75
Fair Value
SEK 768.00
Uncertainty
Medium
1-Star Price
SEK 916.95
5-Star Price
SEK 98.60
Economic Moat
Mdnh
Capital Allocation
Lmmkxxt

Bulls Say, Bears Say

Bulls

We estimate that the Asia-Pacific marketplace could support up to 5,000 additional linac installations. Given Elekta's strong ties with emerging-market customers, particularly in China, we believe the company can grab a sizable portion of greenfield in this region.

Bears

GenesisCare order book in the U.S. has been written down, dealing another blow to the company's U.S. plans.

Trading Information

Previous Close Price
SEK 70.05
Day Range
SEK 69.8570.90
52-Week Range
SEK 61.4590.00
Bid/Ask
SEK 70.55 / SEK 70.60
Market Cap
SEK 27.03 Bil
Volume/Avg
943,417 / 1.1 Mil

Key Statistics

Price/Earnings (Normalized)
19.07
Price/Sales
1.48
Dividend Yield (Trailing)
3.43%
Dividend Yield (Forward)
3.43%
Total Yield
3.43%

Company Profile

Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,000 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and the Asia-Pacific contributing the remainder.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Core
Total Number of Employees
4,566

Competitors

Valuation

Metric
EKTA B
SHL
BDX
Price/Earnings (Normalized)
19.0724.2718.67
Price/Book Value
2.503.212.66
Price/Sales
1.482.653.51
Price/Cash Flow
10.2520.8118.92
Price/Earnings
EKTA B
SHL
BDX

Financial Strength

Metric
EKTA B
SHL
BDX
Quick Ratio
0.740.791.20
Current Ratio
0.991.271.85
Interest Coverage
5.156.364.20
Quick Ratio
EKTA B
SHL
BDX

Profitability

Metric
EKTA B
SHL
BDX
Return on Assets (Normalized)
3.75%4.04%3.65%
Return on Equity (Normalized)
11.19%10.35%7.60%
Return on Invested Capital (Normalized)
8.20%11.27%5.30%
Return on Assets
EKTA B
SHL
BDX

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
DqrjwmxflRqzfdnh$196.0 Bil
Stryker Corp
SYK
DmhfwgvgVjqb$133.8 Bil
Boston Scientific Corp
BSX
ZbbtjfyqgMtwrrqb$124.5 Bil
Medtronic PLC
MDT
KktbbzvnHdxvxdd$113.2 Bil
Edwards Lifesciences Corp
EW
RchmznvtrWxxqgz$39.5 Bil
Koninklijke Philips NV ADR
PHG
LxvdCbbz$30.1 Bil
DexCom Inc
DXCM
ZfkjwtjbhxCmj$27.3 Bil
Steris PLC
STE
CvkfrxdTywhs$22.8 Bil
Zimmer Biomet Holdings Inc
ZBH
GjjgzdjtlJjhkg$21.3 Bil
Insulet Corp
PODD
FcclnvytpdHqdrzqp$16.1 Bil

Sponsor Center